You searched for "BURST"
Intravesical cytosine arabinoside + Mitomycin C for bladder cancer – is it beneficial?
Mitomycin C (MMC) is often used as an intravesical therapy for low / intermediate risk non-muscle invasive bladder cancer. This randomised controlled trial (RCT) was designed to assess the safety and efficacy of MMC + cytosine arabinoside (Ara-C). Ara-C was...BAUS Innovations Webinar with Intuitive: Exploring the use of da Vinci SP in Robotic Surgery
@ 7:00PM – 8:00PM Join distinguished guest speakers Mr Ben Challacombe (Guy’s and St Thomas’) and Professor Chris Eden (London Bridge Hospital) as they share their extensive experience, clinical insights, and data surrounding SP surgery, chaired by Alison Rowan, Snr Marketing Manager, Intuitive. From real-world outcomes to surgical technique, this is an invaluable opportunity to hear from two of the UK’s leading robotic surgeons.‘Man van’ launched to speed up cancer diagnosis and improve healthcare access
The ‘Man Van’, an innovative new outreach programme, was launched in March this year to provide free health checks for men and boost early diagnosis of prostate and other urological cancers. The mobile health clinic will visit workplaces and churches...iMEDicare – Pelvic Health Naturally are on a mission
Since 2022, the team at iMEDicare has been scaling the highest peaks of various European nations to raise funds for a selection of their favourite charities. Their mountain adventures have so far taken them to the top of Scotland, Wales,...
The importance of second-look transurethral resection for superficial bladder cancer
This was a prospective study of 100 consecutive patients with a newly diagnosed superficial bladder tumour who underwent a second look transurethral resection of bladder tumour (TURBT) two to six weeks post initial resection. This essentially included pTa multiple and...
The cost of bladder cancer: what can be done?
The rising cost of cancer care is a growing concern for health systems. A 2020 study estimated Europe’s annual cancer-related expenditure at €199 billion, with €109 billion attributed to healthcare costs. Bladder cancer (BC), in particular, imposes a significant financial...Nurse practitioner TRUS biopsy: training and preparation
As prostate cancer rates increase, many urology departments rely on multi-professional teams to diagnose and manage patients with prostate cancer. The aim of this article is to highlight the skills, training and preparation required for nurse practitioners to undertake trans-rectal...Exciting opportunity for a Full time Band 7 Urology Nurse Specialist
An exciting opportunity has arisen for a Full time Band 7 Urology Nurse Specialist to join The Birmingham Prostate Specialists Service in conjunction with HCA Harborne Hospital, Birmingham. (Part time would be considered) The post holder will be initially supported...Nominations Open for the Action Bladder Cancer UK Nurse of the Year Award 2026
Action Bladder Cancer UK is inviting nominations for its Nurse of the Year Award 2026, recognising the outstanding contribution of nurses who support people affected by bladder cancer. Do you know a nurse who has gone above and beyond? They...Bladder cancer
Case 1 A 78-year-old female presents with a week history of painless haematuria. She’s a smoker and used to work in the textiles industry. She underwent a flexible cystoscopy. What does this image show? What are the two-week wait National...
